Citadel Advisors - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q2 2023$297,419
-35.9%
183,592
-15.7%
0.00%
Q1 2023$463,869
+23.5%
217,779
+114.6%
0.00%
Q4 2022$375,550
+2247.2%
101,500
+381.0%
0.00%
Q3 2022$16,000
-92.0%
21,100
-91.8%
0.00%
Q2 2022$199,000
+610.7%
256,415
+727.1%
0.00%
Q1 2022$28,000
-98.7%
31,000
-88.6%
0.00%
Q4 2021$2,175,000
+23.6%
271,369
+29.2%
0.00%
Q3 2021$1,759,000
+121.8%
210,106
+78.6%
0.00%
Q2 2021$793,000
-10.0%
117,630
-11.7%
0.00%
Q1 2021$881,000
+1195.6%
133,176
+722.1%
0.00%
Q4 2020$68,000
-48.1%
16,200
-25.0%
0.00%
Q2 2020$131,000
-31.1%
21,600
-37.4%
0.00%
Q1 2020$190,000
-50.0%
34,500
-47.7%
0.00%
Q3 2019$380,000
-2.8%
65,996
+53.4%
0.00%
Q2 2019$391,000
-65.8%
43,025
-47.7%
0.00%
-100.0%
Q1 2019$1,142,000
+39.4%
82,339
+58.4%
0.00%
Q4 2018$819,000
+695.1%
51,972
+334.5%
0.00%
Q4 2015$103,000
-48.0%
11,960
-12.3%
0.00%
Q3 2015$198,000
-8.8%
13,636
+4.9%
0.00%
Q2 2015$217,000
+3.3%
13,002
+35.5%
0.00%
Q1 2015$210,000
-88.8%
9,597
-91.2%
0.00%
-100.0%
Q3 2014$1,869,000108,7150.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders